SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-08-202170
Filing Date
2008-09-26
Accepted
2008-09-26 16:30:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 425 19540
2 AGREEMENT AND PLAN OF MERGER dex21.htm EX-2.1 467640
3 FORM OF CONTINGENT VALUE RIGHTS AGREEMENT dex101.htm EX-10.1 66325
  Complete submission text file 0001193125-08-202170.txt   555460
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33093 | Film No.: 081091563
SIC: 2834 Pharmaceutical Preparations